103 related articles for article (PubMed ID: 21040762)
1. Global gene expression profiles of MT knockout and wild-type mice in the condition of doxorubicin-induced cardiomyopathy.
Shuai Y; Guo J; Dong Y; Zhong W; Xiao P; Zhou T; Zhang L; Peng S
Toxicol Lett; 2011 Jan; 200(1-2):77-87. PubMed ID: 21040762
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment.
Shuai Y; Guo JB; Peng SQ; Zhang LS; Guo J; Han G; Dong YS
Toxicol Lett; 2007 Apr; 170(1):66-74. PubMed ID: 17382496
[TBL] [Abstract][Full Text] [Related]
3. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity.
Jing L; Wu Y; Wu J; Zhao J; Zuo D; Peng S
Eur J Pharmacol; 2011 Jun; 659(2-3):224-32. PubMed ID: 21463615
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity.
Merten KE; Feng W; Zhang L; Pierce W; Cai J; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1314-9. PubMed ID: 16144979
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein acts as a cytoprotectant against doxorubicin toxicity.
Kimura T; Fujita I; Itoh N; Muto N; Nakanishi T; Takahashi K; Azuma J; Tanaka K
J Pharmacol Exp Ther; 2000 Jan; 292(1):299-302. PubMed ID: 10604962
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
8. [Metallothionein inhibited DOX-induced cardiac apoptosis in mice].
Shuai Y; Guo J; Peng SQ; Zhang LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):620-3. PubMed ID: 17718425
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
Wang GW; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):461-8. PubMed ID: 11454906
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1α pathway.
Guo J; Guo Q; Fang H; Lei L; Zhang T; Zhao J; Peng S
Eur J Pharmacol; 2014 Aug; 737():117-24. PubMed ID: 24858368
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein-I/II null cardiomyocytes are sensitive to Fusarium mycotoxin butenolide-induced cytotoxicity and oxidative DNA damage.
Yang HY; Wang YM; Peng SQ
Toxicon; 2010 Jun; 55(7):1291-6. PubMed ID: 20144643
[TBL] [Abstract][Full Text] [Related]
12. JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes.
Rong J; Li L; Jing L; Fang H; Peng S
Int J Toxicol; 2016 May; 35(3):317-26. PubMed ID: 26526549
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
Wu HY; Kang YJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
[TBL] [Abstract][Full Text] [Related]
14. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
15. Microarray and Co-expression Network Analysis of Genes Associated with Acute Doxorubicin Cardiomyopathy in Mice.
Wei SN; Zhao WJ; Zeng XJ; Kang YM; Du J; Li HH
Cardiovasc Toxicol; 2015 Oct; 15(4):377-93. PubMed ID: 25575753
[TBL] [Abstract][Full Text] [Related]
16. Genetic background but not metallothionein phenotype dictates sensitivity to cadmium-induced testicular injury in mice.
Liu J; Corton C; Dix DJ; Liu Y; Waalkes MP; Klaassen CD
Toxicol Appl Pharmacol; 2001 Oct; 176(1):1-9. PubMed ID: 11578143
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels.
Wang GW; Kang YJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):938-44. PubMed ID: 10027829
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administration.
Salleh MN; Ismail P; Abdullah AS; Taufiq-Yap YH
IUBMB Life; 2004 Jul; 56(7):409-16. PubMed ID: 15545218
[TBL] [Abstract][Full Text] [Related]
19. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice.
Nozaki N; Shishido T; Takeishi Y; Kubota I
Circulation; 2004 Nov; 110(18):2869-74. PubMed ID: 15505089
[TBL] [Abstract][Full Text] [Related]
20. Analysis of metallothionein brain gene expression in relation to ethanol preference in mice using cosegregation and gene knockouts.
Loney KD; Uddin RK; Singh SM
Alcohol Clin Exp Res; 2006 Jan; 30(1):15-25. PubMed ID: 16433728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]